These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29782299)

  • 1. Drug-induced Subacute Cutaneous Lupus Erythematosus Caused by a Topical Beta Blocker - Timolol.
    Bilewicz-Stebel M; Miziołek B; Bergler-Czop B; Stańkowska A
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):44-47. PubMed ID: 29782299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced cutaneous lupus erythematosus: 88 new cases.
    Laurinaviciene R; Sandholdt LH; Bygum A
    Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.
    Sontheimer RD; Henderson CL; Grau RH
    Arch Dermatol Res; 2009 Jan; 301(1):65-70. PubMed ID: 18797894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
    Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
    Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acebutolol-induced subacute cutaneous lupus erythematosus.
    Fenniche S; Dhaoui A; Ammar FB; Benmously R; Marrak H; Mokhtar I
    Skin Pharmacol Physiol; 2005; 18(5):230-3. PubMed ID: 16015021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use.
    Patane' S; Marte F; Di Bella G; Pugliatti P
    Int J Cardiol; 2008 Jun; 126(3):e43-6. PubMed ID: 17418438
    [No Abstract]   [Full Text] [Related]  

  • 9. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subacute cutaneous lupus erythematosus induced by terbinafine].
    Amitay-Layish I; Feuerman H; David M
    Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute cutaneous lupus erythematosus induced by nifedipine.
    Gubinelli E; Cocuroccia B; Girolomoni G
    J Cutan Med Surg; 2003; 7(3):243-6. PubMed ID: 12574905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.
    Figueredo Zamora E; Callen JP; Schadt CR
    Lupus; 2021 Apr; 30(4):661-663. PubMed ID: 33349110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual.
    Shapiro M; Sosis AC; Junkins-Hopkins JM; Werth VP
    Int J Dermatol; 2004 Feb; 43(2):87-94. PubMed ID: 15125497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.
    Xu K; Zhang M; Yang S; Yu G; Zheng P; Qin X; Feng J
    BMC Neurol; 2023 Apr; 23(1):168. PubMed ID: 37101279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.
    Grönhagen CM; Fored CM; Linder M; Granath F; Nyberg F
    Br J Dermatol; 2012 Aug; 167(2):296-305. PubMed ID: 22458771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug induced systemic lupus erythematosus due to ophthalmic timolol.
    Zamber RW; Starkebaum G; Rubin RL; Martens HF; Wener MH
    J Rheumatol; 1992 Jun; 19(6):977-9. PubMed ID: 1404139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy?
    Lis-Święty A; Brzezińska-Wcisło L; Widuchowska M; Kucharz E
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):443-6. PubMed ID: 23537059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.